BMC Medical Genetics · 2019 · 17 citations · 16 references
MedicineGeneticsHematologyEarly DetectionHuman GeneticsMolecular DiagnosticsAnemiaClinical HematologyInherited Disease TestingMolecular ScreeningPrenatal Diagnosis Of HemoglobinopathiesRed Blood Cell DisordersAnemia DiagnosticsComplete Blood Count InterpretationEarly Case DetectionEarly ScreeningHemoglobinopathy ScreeningMolecular Diagnosis Of HemoglobinopathiesPeripheral Blood Count InterpretationPopulation Screening For Hemoglobinopathies
Background Thalassemia is the most common inherited disease in the world, involving α- or β-globin in red blood cells. Thalassemia cases rank fifth in the list of national catastrophic diseases in Indonesia; however, nationwide screening for thalassemia carriers is not yet mandatory. This study aimed to assess whether blood count metrics, such as the Shine & Lal index (SLI; MCV*MCV*MCH/100), might serve as a predictor to screen thalassemia carriers in a limited resource area where molecular methods are not readily available. Methods During a family gathering of thalassemia patients, family members (n196) underwent a complete blood count test. Those with MCV < 80 fL and/or MCH < 27 pg and/or SLI < 1530 were further examined for Hb analysis. Only samples with HbA2 fraction > 4% or with a peak in the HbE fraction were sequenced to confirm β-globin gene mutations. Results Of 196 family members, 117 (59.6%) had low MCV and/or low MCH and/or low SLI. The HbE fraction (mean 24.06% ± 0.95, range 22.4–26.5) was found in 27 (13.7%) cases, and all had a mutation at codon (CD)26 (c.79G > A). The mean HbA2 fraction in these samples was 3.18% ± 0.62 (range 2.6–3.8). For samples with HbA2 > 4% (n30; 15.3%), all had mutations at IVS1nt5 (c.92 + 5 G > C; n28), CD8/9 (c.27_28insG; n1) and CD19 (c.59A > G; n1). The mean HbA2 fraction with a mutation at IVS1nt5 (c.92 + 5 G > C) was 4.65% ± 0.77 (range 4.0–5.6). Interestingly, anaemia was only present in 25 and 57% of β-thalassemia carriers with mutations at CD26 (c.79G > A) and at IVS1nt5 (c.92 + 5 G > C), respectively. Conclusions The Shine & Lal index is helpful in the early screening of β-thalassemia carriers, since this index confirms mutations at CD-26 (c.79G > A) and at IVS1nt5 (c.92 + 5 G > C), which are both common mutations in Bandung, Indonesia. Further DNA analysis is a topic of interest to map variants in globin genes and their distribution across populations.
16
Haemoglobinopathies in southeast Asia.
Suthat Fucharoen, Pranee Winichagoon · PubMed · 2011 · 158 citations
Life Sciences, Genetics, Hematology +12
ICSH recommendations for the measurement of Haemoglobin A<sub>2</sub>
A. D. Stephens, M. Angastiniotis, E. Baysal et al. · International Journal of Laboratory Hematology · 2011 · 101 citations
Medicine, Genetics, Hematology +16